Market Value319,338,992
Total Holdings63
File Date2024-08-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
ANNX / Annexon, Inc.
CYTK / Cytokinetics, Incorporated
BBIO / BridgeBio Pharma, Inc.
SRPT / Sarepta Therapeutics, Inc.
SGMT / Sagimet Biosciences Inc.
ITCI / Intra-Cellular Therapies, Inc.
SNDX / Syndax Pharmaceuticals, Inc.
RAPT / RAPT Therapeutics, Inc. Call
ALNY / Alnylam Pharmaceuticals, Inc.
ALNY / Alnylam Pharmaceuticals, Inc. Put
SVRA / Savara Inc.
REPL / Replimune Group, Inc.
NUVB / Nuvation Bio Inc.
CATX / Perspective Therapeutics, Inc.
JANX / Janux Therapeutics, Inc.
CRNX / Crinetics Pharmaceuticals, Inc.
RZLT / Rezolute, Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
APLS / Apellis Pharmaceuticals, Inc.
RYTM / Rhythm Pharmaceuticals, Inc.
AXSM / Axsome Therapeutics, Inc.
TSHA / Taysha Gene Therapies, Inc.
ROIV / Roivant Sciences Ltd.
IMVT / Immunovant, Inc.
CGON / CG Oncology, Inc.
INSM / Insmed Incorporated
INSM / Insmed Incorporated Call
HLXB / Helix Acquisition Corp. II
KRYS / Krystal Biotech, Inc.
RVNC / Revance Therapeutics, Inc.
MDGL / Madrigal Pharmaceuticals, Inc.
AQST / Aquestive Therapeutics, Inc.
MRNS / Marinus Pharmaceuticals, Inc.
PTGX / Protagonist Therapeutics, Inc.
AVTE / Aerovate Therapeutics, Inc.
NTRA / Natera, Inc.
IMVT / Immunovant, Inc. Call
XBI / SPDR Series Trust - SPDR S&P Biotech ETF Put
GERN / Geron Corporation
RARE / Ultragenyx Pharmaceutical Inc.
LRMR / Larimar Therapeutics, Inc.
QURE / uniQure N.V.
ISR / Perspective Therapeutics Inc
KALV / KalVista Pharmaceuticals, Inc.
VKTX / Viking Therapeutics, Inc. Call
ATXS / Astria Therapeutics, Inc.
COGT / Cogent Biosciences, Inc.
BPMC / Blueprint Medicines Corporation
MGNX / MacroGenics, Inc.
PRQR / ProQR Therapeutics N.V.
NGNE / Neurogene Inc.
PTCT / PTC Therapeutics, Inc.
PMVP / PMV Pharmaceuticals, Inc.
ELEV / Elevation Oncology, Inc.
BHVN / Biohaven Ltd.
CABA / Cabaletta Bio, Inc.
ARVN / Arvinas, Inc.
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
PCVX / Vaxcyte, Inc.
RGNX / REGENXBIO Inc.
SYRE / Spyre Therapeutics, Inc.
ANTX / AN2 Therapeutics, Inc.
TARS / Tarsus Pharmaceuticals, Inc.
ACAD / ACADIA Pharmaceuticals Inc. Call
NTLA / Intellia Therapeutics, Inc.
CTMX / CytomX Therapeutics, Inc.
ARWR / Arrowhead Pharmaceuticals, Inc.
MLTX / MoonLake Immunotherapeutics
CYTK / Cytokinetics, Incorporated Call
ENGN / enGene Holdings Inc.
OLMA / Olema Pharmaceuticals, Inc.
ITCI / Intra-Cellular Therapies, Inc. Call
DCPH / Deciphera Pharmaceuticals, Inc.
VKTX / Viking Therapeutics, Inc.
SLNO / Soleno Therapeutics, Inc.
WVE / Wave Life Sciences Ltd.
EYPT / EyePoint Pharmaceuticals, Inc.
ALT / Altimmune, Inc.
CRBP / Corbus Pharmaceuticals Holdings, Inc.
ACAD / ACADIA Pharmaceuticals Inc.
ANNX / Annexon, Inc. Call
PHAT / Phathom Pharmaceuticals, Inc.
VRDN / Viridian Therapeutics, Inc.
KRRO / Korro Bio, Inc.
TNYA / Tenaya Therapeutics, Inc.
ATYR / aTyr Pharma, Inc.
TGTX / TG Therapeutics, Inc.